Jazz Pharmaceuticals (JAZZ) Asset Utilization Ratio (2011 - 2026)

Jazz Pharmaceuticals' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.38 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 9.33% year-over-year to 0.38; the TTM figure through Mar 2026 stood at 0.38 (up 9.33% YoY), while the FY2025 annual figure was 0.36, up 3.7% from the prior year.
• Asset Utilization Ratio was 0.38 for Q1 2026 at Jazz Pharmaceuticals, up from 0.37 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.38 in Q1 2026 to a low of 0.27 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.34 across 5 years, with a median of 0.34 in 2023.
• Biggest YoY gain for Asset Utilization Ratio was 49.0% in 2022; the steepest drop was 25.19% in 2022.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.34 in 2022, then retreated by 1.61% to 0.34 in 2023, then decreased by 1.18% to 0.34 in 2024, then advanced by 10.59% to 0.37 in 2025, then increased by 1.78% to 0.38 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.38 (Q1 2026), 0.37 (Q4 2025), and 0.37 (Q3 2025), per Business Quant data.